MedXL

Amsino International has acquired the assets of MedXL, including manufacturing facilities in Montreal, Canada, adding two FDA- and Health Canada-registered facilities and a distribution center. The acquisition doubles Amsino's syringe production capacity to over 500 million units annually.

MedXL received a repayable contribution of $2.3 million from Canada Economic Development to acquire digital production equipment, establish a new production line, and increase capacity, creating 25 jobs.